Early Molecular Testing for Presumptive Genetic Eye Diseases
The findings support ophthalmology-focused multigene panels as an effective first-line diagnostic strategy for patients with suspected genetic eye diseases and support future targeted deep phenotypic evaluation, prognosis, and eligibility for emerging gene-specific therapies.